Members Only Area →
Harvey Max Chochinov, OC OM MD PhD FRCPC FRSC FCAHS | Winnipeg, MB
Distinguished Professor of Psychiatry at the University of Manitoba and Senior Scientist at the Research Institute of Oncology and Haematology, CancerCare Manitoba, is one of the world’s most innovative and influential proponents of improved and expanded palliative care across multiple dimensions of life-limiting or life-ending condition. Dr. Chochinov’s pioneering work has significantly advanced effective recognition and treatment of end-of-life distress, depression, desire for death and vulnerability. His empirical research provides guidelines for dignity conserving palliative care and psychosocial intervention and is helping to assure that our medical management of dying and death does not disregard alleviable pain nor violate the dignity of patients and their families.
Dr. Chochinov is Co-Founder and former chair (2001-2015) of the Canadian Virtual Hospice (CVH), the world’s most comprehensive online platform providing information and support to patients, families and health providers on issues related to palliative care and bereavement. His award-winning book Dignity Therapy: Final Words for Final Days is a profound and beautiful meditation on human mortality and a blueprint for the palliative intervention developed by Dr. Chochinov and his research colleagues.
VIEW THE FULL MEDIA RELEASE HERE
The Department of Psychosocial Oncology and Rehabilitation (Tom Baker Cancer Centre, Calgary Alberta) and the Division of Psychosocial Oncology (Cumming School of Medicine, University of Calgary) are recruiting a clinical academic Fellow for the 2022-23 academic year. This opportunity is for interdisciplinary professionals (completing training or fully licensed) who are seeking one year of specialized training in Psychosocial Oncology. Interested applicants are encouraged to send a letter of interest by May 15, 2021. Following an expression of interest, a single chosen candidate will build a tailored application collaboratively with our program, and apply by Aug 31, 2021. Competition results will be announced around November 2021.
Members can learn more about this opportunity HERE
Typically the association holds the annual meeting in conjunction with CAPO conference which is normally held in the spring. This year the conference will be held in June and will again be virtual.
This later date poses a challenge for scheduling the CAPO Annual General Meeting. Our bylaws state that our AGM is to be held within 150 days of the end of our fiscal year (December 31). To ensure compliance with our bylaws the 2021 annual meeting will be held virtually. The bylaws provide for holding meetings electronically. The platform to be used will allow for attendance by Webinar.
MEMBERS RSVP HERE
As the Guest Editors of the Special Issue in Current Oncology described below, we encourage you to consider contributing a paper.
Special Issue Title: Supportive Care Needs of Cancer Patients and Caregivers
Deadline for manuscript submissions: July 31, 2021
Papers will be published on an ongoing basis, immediately upon acceptance after peer review (generally within one week). A publication fee of 1200 CHF will be applied for each accepted paper submitted in 2021 (papers submitted after 30 June 2021 the APC will be 1600 CHF). No extra fees will be applied for color figures.
As an incentive, we have two free publications to offer. To apply to have your paper published free of charge, please send us an abstract and tentative title by May 31, 2021. Submitted abstracts will be evaluated based on innovation, scientific merit, need and whether they have an alternative source of funding.
Dr. Jackie Bender and Dr. Sylvie Lambert
CAPO members can access the discount code and more information by going to Member Resources.
The journal Current Oncology (ISSN 1718-7729, https://www.mdpi.com/journal/curroncol) was transferred from Multimed Inc. to MDPI in late October 2020. We are very excited to continue to develop Current Oncology as an international, scientific, peer-reviewed, open access journal.
Dr. Sharlene Gill from the University of British Columbia has served as Editor-in-Chief of Current Oncology since June 2019 and has kindly agreed to continue to serve in this role. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Current Oncology is indexed by important database including SCIE (IF 2.257), PubMed, MEDLINE, Scopus, etc.
More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol
CAPO Statement on COVID19
Dear Members of the CAPO Community,
These are incredibly difficult times full of uncertainty and fear. For our patients, colleagues and loved ones living with cancer, things are especially challenging.
As always, the psychosocial well-being of our patients, colleagues and family members is our utmost priority.
We also understand that there is an overwhelming amount of information circulating regarding COVID-19.
We have gathered the following resources to help you navigate this unprecedented time.
As of right now, CAPO's 35th Annual Conference scheduled for July 15 to 17 in St. John’s, Newfoundland, is planned to proceed as scheduled. We are however monitoring the situation very closely and will advise if this changes.
As a community – we are here for you.
March 6 is World Lymphedema Day! Lymphedema is chronic inflammatory condition that can develop after cancer treatment. Download the poster
For the first time ever, the Congress will be "Patients Included". We are pleased to welcome the following advocates:
Lorna Larsen @TeamShan: I am honoured to receive a 2019 IPOS/CAPO World Congress of Psycho-Oncology patient and family advocate scholarship. I look forward to participating in the Congress, sharing my daughter Shanna's Story and my efforts to make a positive difference in the adolescent and young adult (AYA) cancer journey. Shanna (Shan) lost her life to breast cancer at the age of twenty-four. As part of my grief process, I have advocated strongly to help improve AYA cancer outcomes across the continuum from awareness to palliative care. All in Shan's memory!
Innovation Grants/Subventions pour l'innovation:
Innovation Grants support the highest quality creative problem solving in cancer research. The goal of the Innovation program is to support the development and testing of transformative, paradigm-shifting concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate novel approaches to confront the challenges we face in defeating cancer.
Budgets awarded may be up to $100,000 per year and a maximum of $200,000 per grant.
It is anticipated that approximately 30 grants will be awarded in this competition.
Please note the following:
Special funding calls within the Innovation Grant competition envelope:
Full application deadline: October 15, 2019
Results announcement: April, 2020
Anticipated start date: May 1, 2020
Please review the full Program Description on our website.
Veuillez consulter la description complète du programme sur notre site Web.
Innovation to Impact Grants/Subventions d’une innovation à un impact:
*Note update to eligibility criteria regarding pursuit of ‘logical next steps’ from an Innovation or CBCF grant.
These grants are intended to support the next phase following a productive CCS Innovation Grant or CBCF research grant, with the goal of working towards or achieving a significant impact on cancer.
Applicants are required to articulate significant achievements from the original Innovation/CBCF Grant (i.e., significant new knowledge, publications, intellectual property, technology development, or relevant endpoints) and clearly describe and justify the progression to the new research proposed. In other words, the original grant and the i2I proposal must be linked by their overarching goal or objective. Applicants must also describe the potential for impact of the proposed project on cancer.
Budgets awarded may be up to $150,000 per year for up to 3 years, to a maximum of $450,000 per grant.
It is anticipated that approximately 15 grants will be awarded in this competition.
Please note that only investigators with a funded Innovation or CBCF research grant with a project end date between January 1, 2017 and April 30, 2020 are eligible for this program.
Results announcement: April 2020
Travel Awards/Bourses de déplacement :
These awards are intended to defray the travel costs associated with making a scientific presentation as a first author or presenter at a conference, symposium or other appropriate professional meeting. PhD, MD, or MD/PhD students, and post-doctoral/medical/clinical fellows are eligible to apply.
There are three competitions in 2019. It is anticipated that approximately 10 Travel Awards will be awarded in each competition (approximately 30 awards per year).
Full application deadline: September 15, 2019
Results announcement: November, 2019
Funding start date: December 1, 2019
Please visit the Canadian Cancer Society research website for program and application information www.cancer.ca/research.
Les renseignements relatifs au programme et à la demande se trouvent sur le site Web de recherche de la Société canadienne du cancer (SCC), au www.cancer.ca/research.
The shared mission of the Canadian Association of Psychosocial Oncology (CAPO) and the International Psycho-Oncology Society (IPOS) is to foster the science and practice of psychosocial oncology to improve the care for people affected by cancer through partnerships, research, public policy, advocacy and education. Our 2019 World Congress will create an opportunity to bring together an international body of health care professionals. This forum encourages new global partnerships and allows for the dissemination of ground-breaking research to professionals and the general public about psycho-oncology, that is, the psychosocial (psychiatric, psychological, social, behavioural, ethical) and psychobiological aspects of oncology. Finally, this forum allows us to recognize exceptional contributions from around the world to the field of psycho-oncology through our awards of excellence.
The following financial support is being made available to patient advocates interested in attending the 2019 Congress:
In order to qualify, applicants must:
Online application review and selection:
The Canadian Association of
Psychosocial Oncology (CAPO)
189 Queen Street East, Suite 1
Toronto, ON M5A 1S2
The Canadian Association of Psychosocial Oncology • Association Canadienne d'Oncologie PsychosocialeWebsite powered by Funnel Communications